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Alongside support for renewed
funding for microbiological
research, many scientists are also
backing a greater role for
international agreements to control
potential biological weapons. But
such efforts present considerable
challenges. One of Britain’s leading
microbiologists, Hugh Pennington
at Aberdeen University, has written
of the ease of obtaining agents
such as anthrax. “In principle any
doctor, dentist, vet, microbiology
graduate or hospital microbiology
lab technologist could produce it.”
Even creating ‘weapons-grade’
material isn’t difficult, he says.
Nonetheless, other researchers
believe that seeking strengthened
international agreements is a way
forward. Brian Heap, vice-
president of Britain’s science
academy, the Royal Society, has
written in an editorial for Science,
that the current Biological
Weapons Convention, signed by
144 states, offers an important
opportunity.
Meeting earlier this month, the
fifth review meeting of the 1972
BWC offers a chance to bolster
controls and gain consensus on the
most effective means of reinforcing
the ban. “It is not possible for any
single nation to protect itself fully
from the malign use of biological
agents without complementary
action by all other countries,” says
Heap. 
He cites the Chemical Weapons
Convention (CWC) as an example
to follow. Now in its fourth year of
full implementation, the CWC
demonstrates that international
instruments can be put into
practice, he says. Unlike the BWC,
the CWC provides an elaborate
international verification system,
which applies to both military
facilities for chemical weapons
defence and to the civil
manufacturing industry, he says.
“Likewise, full cooperation with
the biotechnology and
pharmaceutical industries is
essential to any verification system
for an international instrument
banning biological weapons.”
Many researchers believe they
can play their part in implementing
such an instrument by providing the
tools for diagnosis and detection
and countermeasures, including
novel vaccines and better computer
models to elucidate the source and
dissemination of infectious agents. 
However the Geneva meeting
got off to a rocky start, says Oliver
Meyer, an observer from the non-
governmental organisation, Vertic.
“Some countries such as the US
are sceptical that international
agreement is the way forward in
tackling these weapons,” he says.
But with the still bewildering
anthrax attacks in the US, many
still see collaboration and the BWC
platform as a key way forward.
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